DorianJWilliamsMD

Family Medicine • Morgantown, WV

Associate Dean for Simulation and Technology in Medical Education Professor, Family Medicine and Medical Education, West Virginia University School of Medicine

Join to view full profile

Dr. Williams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Williams' full profile

Already have an account?

Office
1 Medical Center Dr
Morgantown, WV 26506
Phone+1 304-598-6900

Fax+1 304-293-6963

Education & Training

West Virginia UniversityResidency, Family Medicine, 1989 - 1992
West Virginia University School of MedicineClass of 1989

Certifications & Licensure

WV State Medical License 1991 - 2025
PA State Medical License 1992 - 2002
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg Start of enrollment: 2004 Aug 01
Completed
Phase 1
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay Start of enrollment: 2006 Jun 01
Completed
Phase 1
Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg Start of enrollment: 2004 Aug 01
Completed
Phase 1
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System Start of enrollment: 2005 Nov 01
Completed
Phase 1
Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg Start of enrollment: 2005 Jan 01
Completed
Phase 1
Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg Start of enrollment: 2006 Mar 01
Completed
Phase 1
Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg Start of enrollment: 2005 Jul 01
Completed
Phase 1
Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr Start of enrollment: 2006 Oct 01
Terminated
Phase 1
Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg Start of enrollment: 2004 Nov 01
Completed
Phase 1
Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg Start of enrollment: 2004 Aug 01
Completed
Phase 1
Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg Start of enrollment: 2004 Sep 01
Completed
Phase 1
Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg Start of enrollment: 2004 Sep 01
Completed
Phase 1
Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg Start of enrollment: 2005 Jul 01
Completed
Phase 1
Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg Start of enrollment: 2005 Nov 01
Completed
Phase 1
Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg Start of enrollment: 2004 Dec 01
Completed
Phase 1
Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Start of enrollment: 2004 Aug 01
Completed
Phase 1
Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg Start of enrollment: 2005 Nov 01
Completed
Phase 1
Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg Start of enrollment: 2005 Jul 01
Completed
Phase 1
Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg Start of enrollment: 2004 May 01
Completed
Phase 1
Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg Start of enrollment: 2005 Nov 01
Completed
Phase 1
Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg Start of enrollment: 2004 May 01
Completed
Phase 1
Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg Start of enrollment: 2005 Jul 01
Completed
Phase 1
Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg Start of enrollment: 2005 Oct 01
Completed
Phase 1
Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Start of enrollment: 2004 Aug 01
Completed
Phase 1
Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg Start of enrollment: 2003 Dec 01
Completed
Phase 1
Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg Start of enrollment: 2005 Nov 01
Completed
Phase 1
Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg Start of enrollment: 2004 Dec 01
Completed
Phase 1
Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg Start of enrollment: 2005 May 01
Completed
Phase 1
Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg Start of enrollment: 2005 May 01
Completed
Phase 1
Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg Start of enrollment: 2004 Feb 01
Completed
Phase 1
Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg Start of enrollment: 2005 May 01
Completed
Phase 1
Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg Start of enrollment: 2003 Nov 01
Completed
Phase 1
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System Start of enrollment: 2006 Oct 01
Completed
Phase 1
Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg Start of enrollment: 2004 Dec 01
Completed
Phase 1
Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg Start of enrollment: 2004 Feb 01
Completed
Phase 1
Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg Start of enrollment: 2004 Jul 01
Completed
Phase 1
Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg Start of enrollment: 2004 Feb 01
Completed
Phase 1
Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg Start of enrollment: 2004 Nov 01
Completed
Phase 1
Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg Start of enrollment: 2005 Apr 01
Completed
Phase 1
Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg Start of enrollment: 2004 Aug 01
Completed
Phase 1
Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg Start of enrollment: 2005 Oct 01
Completed
Phase 1
Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg Start of enrollment: 2004 Oct 01
Completed
Phase 1
Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg Start of enrollment: 2005 Aug 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case Report.
Mohamad W Salkini, Xuqing Yang, Fayyaz Haider Hashmi, Stanley J Kandzari, Thomas Hogan
Anticancer Research. 2022-03-01
6 citations
Adverse Effects Profile of Dicycloplatin (DCP) Offers Chemotherapeutic Advantage Over Cisplatin and Carboplatin.
Jing Jie Yu, Thomas F. Hogan, Chad Morley, Chad Crigger, Shunchang Jiao
Anticancer Research. 2019-08-01
11 citations
Longitudinal Ultrasound Curriculum Incorporation at West Virginia University School of Medicine: A Description and Graduating Students' Perceptions.
Joseph Minardi, Holly G. Ressetar, Theresa Foreman, Kristen Craig, Melinda Sharon
Journal of Ultrasound in Medicine. 2019-01-01